Reporting from the frontiers of health and medicine
210 followers 70 artikelen/week
Coalition wages campaign for retractions of Richard Lynn’s racist journal articles

A coalition of researchers, historians, and journalists is urging that major scientific publishers, including Elsevier and Springer, retract the racist articles of an academic known — and sometimes lauded for — a long career espousing ideas of racial superiority and eugenics. The call for retraction, made Thursday in a First Opinion published in STAT,...

Thu Jun 20, 2024 20:30
STAT+: Zealand’s amylin-targeting drug shows early potential in obesity

Zealand Pharma on Thursday reported early positive results of an investigational obesity drug that activates a hormone that’s not targeted by popular treatments Wegovy and Zepbound. In one part of a Phase 1b study, petrelintide, which targets the amylin hormone, led to 8.6% weight loss at 16 weeks, more than the 1.7% weight loss among patients taking...

Thu Jun 20, 2024 20:00
STAT+: Doctors Without Borders is closing its widely regarded access-to-medicines campaign

In a surprise move, Doctors Without Borders is closing down its access-to-medicines campaign, which has been credited with ensuring needed drugs and vaccines have been made available to countless patients in low-income countries around the world. The organization plans to close its campaign by the end of this year and create a new effort devoted to...

Thu Jun 20, 2024 17:28
STAT+: Pharmalittle: We’re reading about Lilly lawsuits, Novo Nordisk fires and much more

Rise and shine, everyone, another hot day is on the way. The forecast – at least on this side of the pond – is warning us to find some shade. So to prepare, we are grabbing a parasol and, naturally, brewing a few cups of stimulation to see us through. Our choice today is orange creme. No matter the weather, though, there is work to be done. So please...

Thu Jun 20, 2024 16:27
STAT+: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial

Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected cisgender women from contracting HIV in a large Phase 3 trial. In the study, none of the 2,134 women who received lenacapavir contracted HIV. By comparison, 16 of the 1,068 women who received the long-running daily pill Truvada contracted...

Thu Jun 20, 2024 15:58
Lilly takes more actions against unapproved versions of Mounjaro

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Here in Chicago, temperatures are high and tensions are even higher as two major hot dog restaurants are reportedly beefing. Apparently PETA is involved and taunted one of the restaurants with a “pig mobile” even...

Thu Jun 20, 2024 15:27

Bouw uw eigen nieuws-stroom

Klaar om het te proberen?
Start een 14-daagse proef, geen credit card nodig.

Account aanmaken